Production of Recombinant Peanut Allergen Ara h 2 using Lactococcus lactis.
BACKGROUND
Natural allergen sources can supply large quantities of authentic allergen mixtures for use as immunotherapeutics. However, such extracts are complex, difficult to define, vary from batch to batch, which may lead to unpredictable efficacy and/or unacceptable levels of side effects. The use of recombinant expression systems for allergen production can alleviate some of these issues. Several allergens have been tested in high-level expression systems and in most cases show immunereactivity comparable to their natural counterparts. The gram positive lactic acid bacterium Lactococcus lactis is an attractive microorganism for use in the production of protein therapeutics. L. lactis is considered food grade, free of endotoxins, and is able to secrete the heterologous product together with few other native proteins. Hypersensitivity to peanut represents a serious allergic problem. Some of the major allergens in peanut have been described. However, for therapeutic usage more information about the individual allergenic components is needed. In this paper we report recombinant production of the Ara h 2 peanut allergen using L. lactis.


RESULTS
A synthetic ara h 2 gene was cloned into an L. lactis expression plasmid containing the P170 promoter and the SP310mut2 signal sequence. Flask cultures grown overnight showed secretion of the 17 kDa Ara h 2 protein. A batch fermentation resulted in 40 mg/L recombinant Ara h 2. Purification of Ara h 2 from the culture supernatant was done by hydrophobic exclusion and size separation. Mass spectrometry and N-terminal analysis showed a recombinant Ara h 2 of full length and correctly processed by the signal peptidase. The immunological activity of recombinant Ara h 2 was analysed by ELISA using antibodies specific for native Ara h 2. The recombinant Ara h 2 showed comparable immunereactivity to that of native Ara h 2.


CONCLUSIONS
Recombinant production of Ara h 2 using L. lactis can offer high yields of secreted, full length and immunologically active allergen. The L. lactis expression system can support recombinant allergen material for immunotherapy and component resolved allergen diagnostics.
Glenting
Jacob
J
Bioneer A/S, DK-2970 Hørsholm, Denmark. jag@bioneer.dk.
Poulsen
Lars K
LK
Kato
Kentaro
K
Madsen
Søren M
SM
Frøkiær
Hanne
H
Wendt
Camilla
C
Sørensen
Helle W
HW
Methods Mol Biol. 1995;47:195-9
7550735
Appl Microbiol Biotechnol. 1992 May;37(2):216-24
1368776
Protein Expr Purif. 1997 Feb;9(1):33-9
9116499
Arch Biochem Biophys. 1997 Jun 15;342(2):244-53
9186485
J Allergy Clin Immunol. 1999 Apr;103(4):559-62
10200001
Nat Med. 1999 Apr;5(4):387-91
10202926
J Allergy Clin Immunol. 1999 Nov;104(5):969-77
10550741
Science. 2000 Aug 25;289(5483):1352-5
10958782
Appl Environ Microbiol. 2002 Oct;68(10):5051-6
12324356
Infect Immun. 2003 Apr;71(4):1887-96
12654805
Cochrane Database Syst Rev. 2003;(2):CD002893
12804442
Microbiology. 2003 Aug;149(Pt 8):2193-201
12904559
Protein Expr Purif. 2003 Oct;31(2):250-9
14550644
Vaccine. 2003 Dec 8;22(1):87-95
14604575
Allergy. 2004 Jan;59(1):45-53
14674933
Methods. 2004 Mar;32(3):313-20
14962766
Clin Exp Allergy. 2004 Apr;34(4):583-90
15080811
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003;(94):97-105; discussion 106
15119026
J Allergy Clin Immunol. 2004 Jun;113(6):1013-23; quiz 1024
15208577
Immunol Lett. 2005 Sep 15;100(2):153-8
15899521
Mol Nutr Food Res. 2005 Oct;49(10):963-71
16189800
Biochem J. 2006 May 1;395(3):463-72
16372900
Clin Gastroenterol Hepatol. 2006 Jun;4(6):754-9
16716759
Expert Rev Mol Med. 2007;9(1):1-18
17210088
Microb Cell Fact. 2007;6:12
17417967
Clin Exp Allergy. 1998 Aug;28(8):984-91
9756203
Mol Microbiol. 1999 Apr;32(1):75-87
10216861
Allergy. 1999 Apr;54(4):380-5
10371098
J Allergy Clin Immunol. 2000 Sep;106(3):409-18
10984358
Ann Allergy Asthma Immunol. 2002 Feb;88(2):183-9
11868923
Microb Cell Fact. 2005 Sep 6;4:26
16144545
Appl Environ Microbiol. 1993 Aug;59(8):2730-3
16349028
Immunol Allergy Clin North Am. 2006 May;26(2):191-206, v-vi
16701140
J Allergy Clin Immunol. 2006 Aug;118(2):434-40
16890769
FEBS J. 2006 Oct;273(19):4425-34
16956374
Glycobiology. 2007 Feb;17(2):220-30
17095532
J Allergy Clin Immunol. 2007 Apr;119(4):826-30
17335886
Mol Immunol. 1996 Mar-Apr;33(4-5):399-405
8676891